GRACEcast ALL Subjects audio and video
Highlights in Lung Cancer, 2013: MEK Inhibitors for KRAS Mutation-Positive NSCLC (audio)
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:05:27
- Mais informações
Informações:
Sinopse
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.
